First Biosimilar Drug Approved

As a logged-in member of Lippincott NursingCenter,
read any FREE or NCPD article at no charge!
Membership is free and comes with many benefits.

Note: You must also be a member and log in to purchase articles.

Already a member?
Sign in

Source:

AJN, American Journal of Nursing

July 2015, Volume :115 Number 7 , page 24 - 25 [Buy]

Log In (required for purchase):

Authors

Aschenbrenner, Diane S. MS, RN

Abstract

* Filgrastim-sndz (Zarxio) is the first biosimilar product approved in the United States. It has been determined to be biosimilar to filgrastim (Neupogen).